pathogenesi
primari
vascul
poorli
understood
trigger
event
initi
inflammatori
respons
remain
larg
undefin
primari
vasculitid
commonli
multifactori
disord
involv
environment
genet
immunolog
factor
contribut
immun
dysregul
pathogenesi
primari
vascul
may
vari
one
diseas
anoth
sever
yet
exclus
immunemedi
mechan
implic
trigger
vascular
wall
damag
better
understand
immunolog
aspect
primari
vascul
may
provid
insight
develop
new
therapeut
strategi
immunebas
effector
mechan
vascul
autoantibodydepend
cellmedi
cytotox
antineutrophil
cytoplasm
antibodi
antineutrophil
cytoplasm
antibodi
anca
close
associ
wegen
granulomatosi
wg
microscop
polyangi
mpa
churgstrauss
syndrom
css
renal
limit
vascul
also
call
idiopath
necrot
crescent
glomerulonephr
ncgn
accordingli
smallvessel
vasculitid
commonli
refer
ancaassoci
vascul
seo
stone
anca
group
autoantibodi
direct
enzym
contain
azurophil
granul
neutrophil
two
major
type
anca
describ
basi
indirect
immunofluoresc
pattern
cytoplasm
canca
perinuclear
panca
pattern
canca
pattern
correspond
commonli
proteinas
wherea
panca
antibodi
relat
larg
rang
antigen
common
one
myeloperoxidas
mpo
strongli
associ
wg
high
specif
predict
valu
wherea
mpopanca
seen
commonli
mpa
css
panca
correspond
mpo
antigen
recogn
specif
protein
includ
lactoferrin
elastas
bactericid
permeabilityinhibit
protein
less
specif
report
wide
varieti
inflammatori
infecti
condit
gener
strict
correl
anca
titer
diseas
activ
studi
show
relaps
diseas
often
preced
rise
anca
level
review
seo
stone
although
role
anca
pathophysiolog
smallvessel
vascul
still
debat
sever
experiment
vitro
data
support
anca
directli
pathogen
vitro
data
help
deciph
effect
anca
neutrophil
function
gave
indirect
evid
role
autoantibodi
vascular
damag
anca
activ
neutrophil
prime
tnfa
lead
degranul
releas
lysosom
enzym
well
product
inflammatori
cytokin
reactiv
oxygen
intermedi
falk
et
al
brook
et
al
activ
neutrophil
thu
abl
exhibit
cytotox
effect
toward
endotheli
cell
ewert
et
al
savag
et
al
moreov
anca
capabl
enhanc
neutrophil
adher
endothelium
upregul
adhes
molecul
neutrophil
endotheli
cell
ewert
et
al
johnson
et
al
b
muller
kobold
et
al
direct
effect
anca
endotheli
cell
may
suggest
endotheli
cell
express
anca
antigen
howev
hypothesi
remain
controversi
kallenberg
et
al
strong
evid
pathogen
role
anca
deriv
vivo
studi
experiment
data
studi
mice
show
antimpo
antibodi
trigger
sever
necrot
crescent
glomerulonephr
granulomat
inflamm
system
necrot
vascul
consist
clinic
featur
ancaassoci
vascul
xiao
et
al
interestingli
recipi
mice
defici
b
lymphocyt
role
cellular
effector
function
trigger
tissu
damag
thu
unlik
xiao
et
al
experi
support
role
neutrophil
trigger
tissu
damag
antimpoinduc
diseas
develop
crescent
glomerulonephr
inde
accompani
glomerular
accumul
neutrophil
macrophag
deplet
neutrophil
complet
protect
mice
ancainduc
glomerulonephr
xiao
et
al
contrast
data
obtain
mpoanca
effect
antibodi
anim
model
less
forthcom
tomer
et
al
pfister
et
al
van
der
geld
et
al
suggest
possibl
pathophysiolog
differ
mpoancaand
diseas
franssen
et
al
spars
clinic
data
also
support
pathogen
role
mpoanca
instanc
schlieben
et
al
report
case
newborn
develop
pulmonaryren
syndrom
follow
passiv
placent
transfer
matern
mpopanca
addit
data
use
tri
deciph
initi
pathophysiolog
event
preced
neutrophil
attract
vascular
wall
interestingli
product
activ
neutrophil
infus
renal
rat
arteri
mpoimmun
rat
pauciimmun
vascul
develop
kallenberg
et
al
suggest
kallenberg
et
al
adher
cation
protein
mpo
releas
activ
neutrophil
glomerular
capillari
probabl
initi
mandatori
event
consequ
anca
interact
cognat
antigen
situ
deposit
immun
complex
activ
complement
system
result
neutrophil
attract
neutrophil
subsequ
activ
anca
thu
initi
differ
step
inflammatori
process
altogeth
vitro
vivo
data
suggest
anca
induc
endotheli
damag
neutrophil
activ
lead
degranul
enhanc
bind
vascular
endothelium
releas
neutrophil
chemoattract
thu
sustain
amplifi
inflammatori
loop
previou
prime
neutrophil
cytokin
tnfa
stimuli
may
necessari
enhanc
express
mpo
cell
surfac
neutrophil
make
access
anca
interact
charl
et
al
csernok
et
al
hellmich
et
al
altern
mpo
may
passiv
bind
cell
surfac
unstimul
neutrophil
lead
anca
interact
without
need
prime
hess
et
al
interestingli
sever
studi
point
bind
anca
antigen
express
surfac
neutrophil
insuffici
fulli
activ
cell
interact
anca
fc
gamma
receptor
neutrophil
seem
necessari
reumaux
et
al
bensmith
et
al
antiendotheli
cell
antibodi
aeca
heterogen
antibodi
react
variou
endotheli
cell
antigen
aeca
detect
broad
rang
autoimmun
inflammatori
condit
includ
system
vascul
guilpain
mouthon
preval
aeca
disord
may
vari
one
studi
anoth
discrep
result
may
explain
use
differ
techniqu
sourc
endotheli
cell
belizna
et
al
guilpain
mouthon
key
role
aeca
pathogenesi
system
vascul
remain
unclear
author
consid
presenc
aeca
epiphenomenon
data
howev
may
support
involv
aeca
tissu
damag
takayasu
arter
ta
ancarel
vascul
aeca
report
correl
diseas
activ
chan
et
al
nityanand
et
al
variou
potenti
pathogen
mechan
aeca
describ
studi
report
aeca
could
exert
cytotox
effect
complementdepend
cytotox
kawasaki
diseas
kd
ta
fujieda
et
al
tripathi
et
al
via
antibodydepend
cell
cytotox
ancarel
vascul
savag
et
al
data
suggest
antibodi
could
pathogen
activ
endotheli
cell
lead
upregul
adhes
molecul
inflammatori
cytokin
product
ancamedi
vascul
aeca
may
thu
play
import
role
facilit
neutrophil
adher
endothelium
via
upregul
adhes
molecul
endotheli
cell
del
papa
et
al
purpura
hsp
iga
aeca
may
enhanc
induct
interleukin
il
product
neutrophil
chemoattract
cytokin
yang
et
al
could
thu
involv
neutrophil
recruit
final
circul
aeca
aortic
endotheli
cell
describ
ta
may
involv
diseas
pathogenesi
activ
endotheli
cell
also
via
induct
apoptosi
chauhan
et
al
leukocytoclast
vasculitid
lv
heterogen
disord
character
lesion
often
limit
skin
may
affect
organ
claudi
mediat
larg
extent
circul
antibodi
antibodydepend
effector
mechan
pathogen
role
deposit
immun
complex
lv
well
demonstr
anim
human
experiment
model
accordingli
lv
hypersensit
reaction
similar
obtain
experiment
arthu
reaction
claudi
howev
antigen
involv
variou
lv
differ
often
unidentifi
solubl
immun
complex
form
antigen
excess
circul
deposit
blood
vessel
flow
reduc
bifurc
activ
complement
pathway
immun
complex
result
gener
anaphylatoxin
lead
neutrophil
attract
basophil
degranul
subsequ
releas
histamin
increas
vascular
permeabl
enhanc
neutrophil
migrat
vessel
wall
neutrophil
activ
fc
gamma
receptor
moser
et
al
lead
releas
lysosom
enzym
reactiv
oxygen
intermedi
caus
vascular
injuri
adhes
molecul
cytokin
produc
endotheli
cell
increas
transendotheli
migrat
adhes
neutrophil
claudi
along
key
role
activ
neutrophil
endotheli
cell
direct
cytotox
effect
complement
membran
attack
complex
pathophysiolog
mechan
may
damag
endothelium
kawana
later
phase
lv
character
lymphocyt
infiltr
differ
pathophysiolog
mechan
involv
dendrit
cell
dc
cell
may
initi
secondari
cellmedi
immun
respons
contribut
selfperpetu
diseas
lotti
et
al
apart
broad
rang
smallvessel
vascul
relat
deposit
circul
immun
complex
goodpastur
syndrom
mediat
autoantibodi
basement
membran
kidney
alveoli
antigbm
glomerular
basement
membran
antibodi
bind
antigen
capillari
wall
trigger
antibodydepend
cytotox
mechan
lead
tissu
damag
howev
compel
data
suggest
unlik
lv
cellmedi
event
involv
differ
cell
subset
also
implic
goodpastur
syndrom
ooi
et
al
lymphocyt
respons
granuloma
format
characterist
featur
larg
vascular
vascul
activ
cellular
immun
respons
orchestr
lymphocyt
lead
emerg
inflammatori
process
throughout
arteri
wall
layer
panarter
dc
locat
adventitiamedia
border
activ
unknown
antigen
crucial
role
initi
wall
inflamm
activ
dc
thu
provid
necessari
costimulatori
signal
trigger
cell
activ
also
produc
sever
chemokin
therefor
recruit
lymphocyt
macrophag
vascular
wall
activ
lymphocyt
undergo
clonal
expans
secret
ifnc
play
key
role
activ
effector
function
macrophag
vicin
cell
macrophag
releas
inflammatori
cytokin
adventitia
wherea
mediaintima
border
secret
metalloproteinas
reactiv
oxygen
intermedi
lead
fragment
intern
elast
lamina
trigger
intim
hyperplasia
neoangiogenesi
salvarani
et
al
takayasu
arter
ta
giant
cell
arter
gca
granulomat
largevessel
vascul
affect
vital
arteri
caus
vascular
complic
either
lumin
occlus
vessel
wall
destruct
ta
gca
typic
differ
age
onset
vascular
structur
target
inflamm
weyand
goronzi
inde
ta
typic
manifest
aorta
main
branch
pulmonari
arteri
young
woman
wherea
gca
affect
aorta
distal
extracrani
branch
individu
although
ta
gca
classic
consid
distinct
basi
differ
epidemiolog
clinic
featur
detail
clinic
examin
reveal
similar
sign
symptom
often
present
diseas
albeit
differ
frequenc
support
disord
diseas
broad
spectrum
phenotyp
maksimowiczmckinnon
et
al
similar
histolog
abnorm
vasculitid
support
hypothesi
actual
ta
gca
share
pathogen
process
distinguish
vasculitid
compel
datafocus
mostli
gca
access
inflam
vascular
lesionspoint
largevessel
vasculitid
tcellmedi
diseas
weyand
goronzi
vascular
lesion
character
inflammatori
infiltr
often
granulomat
arrang
distribut
panarter
throughout
arteri
wall
layer
preferenti
locat
intimamedia
junction
salvarani
et
al
patchi
granulomat
infiltr
compos
lymphocyt
macrophag
multinucl
giant
cell
weyand
goronzi
ta
lymphocyt
popul
compos
variabl
percentag
lymphocyt
nk
cell
cd
cell
seko
et
al
demonstr
mous
chimera
model
cell
key
cellular
player
orchestr
inflammatori
respons
vascular
wall
brack
et
al
gca
lymphocyt
produc
ifnc
thu
induc
maintain
inflammatori
infiltr
howev
ifncproduc
lymphocyt
repres
minor
subset
tissueinfiltr
cell
preferenti
aggreg
adventiti
layer
vascular
wall
intim
associ
antigenpres
cell
activ
latter
lymphocyt
secret
ifnc
interact
macrophag
lead
format
granuloma
predominantli
medial
layer
vascular
wall
ifnc
inde
major
activ
factor
macrophag
function
interestingli
monocytemacrophag
cytokin
classic
associ
granuloma
formationi
absent
gca
lesion
krupa
et
al
role
altern
monokin
cytokinei
suggest
takayasu
arter
similar
pathophysiolog
mechan
tissu
lesion
seem
involv
howev
cytotox
effector
function
lymphocyt
suggest
inde
divers
perforinsecret
killer
cell
cd
lymphocyt
natur
killer
cell
cytotox
lymphocyt
involv
pathogenesi
vascular
damag
ta
seko
et
al
cytotox
cell
seem
trigger
part
activ
pathway
express
well
ligand
mica
significantli
enhanc
infiltr
cell
aortic
tissu
respect
seko
et
al
role
cd
cell
support
addit
data
obtain
seko
et
al
inde
cd
cellswhich
repres
nearli
infiltr
cellsexhibit
restrict
repertoir
indic
recogn
specif
local
express
antigen
seko
et
al
interestingli
recent
studi
suggest
antiaort
endotheli
cell
antibodi
may
play
role
vascular
dysfunct
ta
implic
autoantibodi
tcellmedi
diseas
remain
clarifi
chauhan
et
al
nonetheless
strong
evid
suggest
ab
lymphocyt
key
player
pathogenesi
largevessel
vascul
although
cell
infiltr
tissu
gca
highli
divers
clonotyp
ident
cell
receptor
isol
distinct
vascular
lesion
patient
peripher
blood
suggest
specif
antigen
present
arteri
wall
recogn
small
fraction
cell
differ
locat
weyand
et
al
martineztaboada
et
al
mous
chimera
model
perform
brack
et
al
support
hypothesi
vascular
inflamm
orchestr
small
number
cell
clonotyp
specif
local
express
antigen
inde
tempor
arteri
biopsi
specimen
patient
gca
engraft
mice
sever
combin
immunodefici
scid
cell
clonotyp
ident
cell
receptor
expand
differ
mice
engraft
tissu
specimen
patient
furthermor
adopt
transfer
syngen
tissuederiv
cell
engraft
scid
maintain
vascular
lesion
gca
human
arterymous
chimera
brack
et
al
compar
data
obtain
ta
restrict
usag
tcr
v
v
b
gene
infiltr
cell
takayasu
arter
suggest
presenc
specif
recogn
antigen
aortic
tissu
seko
et
al
howev
target
antigen
recogn
cell
remain
undetermin
weyand
goronzi
implic
infecti
agent
support
epidemiolog
studi
presenc
genom
materi
parvoviru
chlamydia
pneumonia
demonstr
tempor
biopsi
gca
patient
gabriel
et
al
wagner
et
al
haugeberg
et
al
data
corrobor
studi
helweglarsen
et
al
regan
et
al
nevertheless
experiment
model
suggest
media
larg
elast
arteri
immunoprivileg
site
favor
persist
pathogen
selfantigen
lead
chronic
vascular
diseas
restrict
great
elast
arteri
dal
canto
et
al
strong
evid
suggest
vascular
dc
activ
adapt
innat
immun
play
central
role
trigger
perpetu
situ
inflamm
determin
site
specif
architectur
emerg
vascul
human
medium
larg
arteri
fact
popul
dc
locat
mediaadventitia
border
act
sentinel
sampl
antigen
vascular
environ
tempor
arteri
affect
gca
dc
highli
enrich
activ
indic
express
thu
provid
necessari
costimulatori
signal
cell
trigger
activ
krupa
et
al
dct
cell
interact
involv
product
krupa
et
al
weyand
et
al
activ
dc
produc
sever
chemokin
thu
play
critic
role
recruit
cell
vascular
wall
activ
vascular
dc
also
express
ligand
chemokin
explain
cell
trap
within
vascular
infiltr
weyand
goronzi
notabl
vascular
dc
display
broad
spectrum
patternrecognit
receptor
recogn
seri
pathogenderiv
product
thu
play
import
role
interfac
innat
adapt
immun
compel
recent
data
demonstr
engag
dc
innat
immun
receptor
involv
determin
either
local
pattern
vascular
inflamm
inde
sever
report
show
sens
bacteri
pathogen
vascular
dc
may
initi
perpetu
adapt
immun
respons
vessel
weyand
et
al
pryshchep
et
al
addit
pryshchep
et
al
point
restrict
featur
inflamm
certain
anatom
site
within
vascular
tree
seem
govern
select
pattern
tolllik
receptor
tlr
express
pryshchep
et
al
recent
work
perform
deng
et
al
demonstr
architectur
emerg
arter
also
regul
vascular
dc
depend
type
tlr
engag
inde
ligat
lead
transmur
panarter
wherea
activ
promot
adventiti
perivascul
author
show
furthermor
dc
preferenti
produc
result
recruit
activ
cell
subset
seem
implic
mediat
vascul
gca
thu
differ
bacteri
pathogen
may
induc
distinct
vascul
depend
origin
danger
signal
vascular
dc
shape
emerg
immun
respons
differenti
recruit
special
effector
cell
thu
trigger
distinct
type
vascul
yet
etiolog
agent
initi
largevessel
vascul
defin
suggest
deng
et
al
categor
patient
largevessel
vascul
accord
pattern
inflamm
may
help
investig
etiolog
agent
mention
macrophag
also
crucial
compon
inflammatori
vascular
infiltr
gca
differ
subset
macrophag
distinguish
situ
thu
macrophag
produc
proinflammatori
cytokin
local
vicin
ifncsecret
cell
site
inflamm
adventitia
collagenaseproduc
macrophag
accumul
intimamedia
border
inflam
vessel
suggest
implic
tissu
injuri
weyand
et
al
activ
macrophag
intimamedia
junction
also
produc
metalloproteas
reactiv
oxygen
intermedi
thu
play
central
role
medialwal
damag
lead
nonstenosi
arter
review
weyand
goronzi
chronic
activ
macrophag
may
induc
appear
multinucl
giant
cell
latter
cell
associ
fragment
intern
elast
lamina
weyand
goronzi
product
larg
amount
growth
factor
plateletderiv
growth
factor
pdgf
angiogen
cytokin
giant
cell
macrophag
may
lead
promin
hyperplasia
intima
associ
increas
neovascular
caus
lumenocclus
complic
kaiser
et
al
kaiser
et
al
interestingli
activ
monocytesmacrophag
restrict
vessel
wall
gca
also
note
peripher
blood
suggest
implic
cell
system
inflammatori
syndrom
wagner
et
al
sever
studi
demonstr
associ
diseas
specif
human
leukocyt
antigen
hla
allel
immunerel
gene
support
immunopatholog
mechan
patient
gca
polymyalgia
rheumatica
pmr
close
relat
frequent
associ
diseaseth
commonli
identifi
genet
associ
allel
weyand
et
al
polymorph
hlab
mica
gene
recent
associ
suscept
gca
suggest
sever
gene
within
mhc
might
independ
effect
suscept
vascul
gonzalezgay
et
al
allel
variant
hlab
also
associ
ta
identifi
allel
vari
one
ethnic
group
anoth
result
conflict
data
dong
et
al
yoshida
et
al
charoenwongs
et
al
kitamura
et
al
mehra
jaini
salazar
et
al
lee
et
al
soto
et
al
interestingli
polymorph
gene
encod
ino
kappablik
protein
recent
suggest
associ
suscept
gca
ta
respect
gonzalezgay
et
al
shibata
et
al
allel
variant
ino
associ
gca
relat
increas
promot
activ
higher
product
nitric
oxid
may
possibl
play
role
pathogenesi
vascul
gonzalezgay
et
al
final
better
identif
pathogen
pathway
gca
ta
may
help
identifi
novel
potenti
therapeut
target
henc
rais
possibl
innov
use
therapeut
applic
weyand
goronzi
sever
studi
suggest
play
key
role
sustain
diseas
activ
gca
thu
support
concept
potenti
therapeut
target
weyand
et
al
import
role
tnfa
gca
support
express
tnfa
site
inflamm
well
increas
serum
level
cytokin
patient
refractori
corticosteroid
treatment
evid
accumul
antitnfa
monoclon
therapi
may
altern
treatment
patient
either
gca
ta
respond
classic
treatment
della
rossa
et
al
tanaka
et
al
uthman
et
al
howev
caution
remain
necessari
data
confirm
random
trial
attract
therapeut
may
target
ifnc
growth
factor
vegf
vascular
endotheli
growth
factor
pdgf
metalloproteinas
reactiv
oxygen
intermedi
neutral
cell
stimul
target
costimul
seem
anoth
attract
therapeut
approach
salvarani
et
al
pagnoux
guillevin
strikingli
overal
incid
pan
decreas
last
decad
support
implic
infecti
agent
etiolog
factor
old
report
suggest
deposit
circul
immun
complex
within
vessel
wall
key
player
trigger
inflammatori
vascul
trepo
et
al
zuckerman
pernic
et
al
hbv
infect
associ
pan
commonli
character
high
viral
replic
hbe
antigenemia
support
pathogen
role
viral
agab
complex
deposit
antigen
excess
studi
kidney
renal
arteri
avail
hbv
antigen
involv
deposit
immun
complex
remain
poorli
defin
trepo
guillevin
hbvpan
patient
effici
plasma
exchang
support
pan
immun
complexmedi
diseas
guillevin
et
al
test
hbv
pan
essenti
clinic
manifest
treatment
outcom
pan
depend
presenc
absenc
hbv
infect
inde
patient
hbv
infect
glomerulonephr
anca
almost
absent
diseas
rare
relaps
guillevin
et
al
accur
diagnosi
pan
subtyp
may
lead
effect
treatment
pan
associ
hbv
infect
patient
usual
treat
corticosteroid
immunosuppress
hbvpan
patient
basi
etiolog
role
hbv
treatment
consist
combin
antivir
treatment
plasma
exchang
preced
shortterm
administr
corticosteroid
aim
control
sever
manifest
guillevin
et
al
kawasaki
diseas
kd
inflammatori
vascul
occur
earli
childhood
frequent
involv
coronari
arteri
thu
repres
primari
caus
acquir
heart
diseas
children
aneurysm
appear
week
onset
fever
approxim
untreat
children
intraven
immunoglobulin
ivig
shown
prevent
coronari
aneurysm
format
reduc
fever
myocard
pauciti
clinic
materi
avail
studi
preclud
complet
understand
patholog
featur
vascular
inflamm
kd
burn
glode
nevertheless
earliest
patholog
chang
vessel
appear
accumul
cell
macrophag
monocyt
subendothelium
preced
transmur
inflamm
iga
plasma
cell
also
found
inflammatori
infiltr
aneurysm
format
result
destruct
media
burn
glode
caus
kd
unknown
yet
howev
suggest
kd
result
abnorm
immun
respons
variou
infecti
agent
genet
suscept
children
burn
glode
sever
virus
new
coronaviru
parvoviru
bocaviru
cytomegaloviru
etc
implic
pinna
et
al
report
suggest
contribut
bacteri
superantigen
etiolog
kd
matsubara
fukaya
theori
remain
larg
debat
investig
demonstr
oligoclon
iga
respons
within
vascular
wall
kd
patient
support
involv
convent
antigen
rather
superantigen
rowley
et
al
collect
data
obtain
rowley
colleagu
support
theori
inhal
pathogen
burn
glode
variou
epidemiolog
data
support
implic
genet
predisposit
kd
burn
glode
sever
polymorph
relat
kd
suscept
describ
pinna
et
al
eleftheri
et
al
interestingli
larg
genet
studi
point
import
genet
variat
receptorligand
coupl
suscept
kd
burn
et
al
burgner
et
al
recent
report
first
genomewid
associ
studi
identifi
novel
variant
associ
diseas
predisposit
major
recent
studi
onouchi
et
al
report
associ
function
polymorph
inositol
triphosph
itpkc
kd
suscept
tpkc
act
neg
regul
cell
activ
author
suggest
implic
describ
polymorph
immun
hyperreact
kd
therefor
support
role
cell
pathogenesi
vascul
accordingli
quantit
defect
regulatori
cell
peripher
blood
kd
patient
demonstr
acut
phase
diseas
corrobor
hypothesi
furuno
et
al
activ
monocytesmacrophag
may
also
play
key
role
kd
burn
glode
serum
level
proinflammatori
monokin
inde
significantli
enhanc
acut
phase
diseas
activ
monocytesmacrophag
demonstr
either
peripher
blood
vascular
lesion
burn
glode
smallvessel
vascul
leukocytoclast
vascul
lv
leukocytoclast
vasculitid
heterogen
disord
character
lesion
commonli
limit
skin
may
involv
organ
joint
kidney
lotti
et
al
lv
smallvessel
inflammatori
diseas
mediat
mostli
deposit
immun
complex
mani
factor
infect
drug
chemic
substanc
diseas
associ
immun
complex
accus
pathogenesi
lv
claudi
histolog
skin
lesion
character
dermal
smallvessel
necrot
inflamm
often
leukocytoclasi
claudi
deposit
igg
igm
andor
complement
around
vessel
wall
usual
detect
earli
phase
report
indic
may
notic
variou
timepoint
grunwald
et
al
iga
found
diagnosi
hsp
suspect
hypocomplementemia
present
polymorphonuclear
neutrophil
pnn
infiltr
dens
cover
whole
dermi
hypocomplementem
vascul
claudi
interestingli
wherea
implic
deposit
immun
complex
initi
phase
lv
well
demonstr
pathogen
mechan
seem
involv
later
stage
character
lymphocyt
infiltr
lotti
et
al
therapeut
approach
requir
remov
caus
agent
identifi
otherwis
variou
local
system
antiinflammatori
immunosuppress
therapi
recommend
lotti
et
al
purpura
hsp
common
childhood
primari
system
vascul
although
caus
unknown
like
iga
central
role
pathogenesi
diseas
accordingli
iga
deposit
vascular
lesion
hsp
characterist
featur
diseas
emerg
recent
import
diagnost
criterion
ozen
et
al
furthermor
evid
increas
serum
iga
concentr
circul
igacontain
immun
complex
support
hypothesi
interestingli
hsp
iga
nephropathya
relat
diseasear
associ
abnorm
glycosyl
olink
oligosaccharid
uniqu
hing
region
molecul
lau
et
al
aberrantli
glycosyl
prone
induc
iga
aggreg
form
macromolecul
complex
possibl
mechan
underli
deposit
iga
immun
complex
vessel
wall
renal
mesangium
saulsburi
specif
iga
antibodi
hsp
address
although
presenc
iga
anca
still
debat
ozaltin
et
al
autoantibodi
iga
anticardiolipin
antibodi
iga
rheumatoid
factor
describ
saulsburi
yang
et
al
recent
studi
yang
et
al
report
circul
iga
hsp
direct
endotheli
cell
antibodi
abl
activ
endotheli
cell
trigger
product
yang
et
al
yang
et
al
henc
implic
aeca
pnn
infiltrationanoth
characterist
featur
vascular
lesion
hspha
rais
level
proinflammatori
cytokin
tnfa
commonli
increas
acut
phase
hsp
support
immunemedi
pathophysiolog
mechan
yang
et
al
moreov
deregul
tgfb
product
report
hsp
serum
level
tgfb
higher
acut
hsp
tgfbsecret
cell
activ
acut
stage
hsp
yang
et
al
yang
et
al
tgfb
major
immunosuppress
cytokin
also
act
switch
factor
iga
secret
henc
activ
tgfbsecret
cell
may
explain
preferenti
differenti
igaproduc
cell
hsp
accordingli
increas
number
circul
igaproduc
cell
specif
featur
hsp
may
differenti
entiti
form
leukocytoclast
vascul
casanueva
et
al
famili
cluster
hsp
may
indic
contribut
genet
background
environment
trigger
shin
lee
zhang
et
al
polymorph
sever
gene
antagonist
vegf
associ
diseas
suscept
andor
prognosi
renal
involv
yang
et
al
interest
report
describ
increas
frequenc
tgfb
polymorph
promot
region
hsp
polymorph
relat
higher
transcript
activ
gene
increas
plasma
level
yang
et
al
strikingli
polymorph
seem
associ
sever
clinic
present
environment
factor
particularli
infect
appear
trigger
factor
yang
et
al
accordingli
hsp
preced
upper
respiratori
tract
infect
patient
wide
rang
infecti
agent
report
potenti
trigger
hsp
role
anteced
streptococc
infect
commonli
rais
still
debat
alsheyyab
et
al
recent
data
report
presenc
group
streptococc
antigen
glomeruli
children
hsp
may
suggest
role
streptococc
infect
pathogenesi
nephriti
masuda
et
al
report
yang
et
al
sever
pathogen
mechan
may
underli
contribut
infect
diseas
trigger
yang
et
al
altogeth
strong
evid
suggest
hsp
postinfecti
inflammatori
diseas
lead
differenti
igaproduc
plasma
cell
iga
immun
complex
deposit
vascular
wall
renal
mesangium
lead
activ
complement
subsequ
tissu
injuri
whether
iga
immun
complex
form
situ
deposit
circul
complex
still
debat
yang
et
al
suggest
circul
iga
may
crossreact
endotheli
cell
directli
lead
endotheli
damag
complement
activ
iga
antiendotheli
autoantibodi
may
also
act
endotheli
cell
enhanc
product
subsequ
would
recruit
activ
pnn
caus
vascular
damag
releas
toxic
granul
content
reactiv
oxygen
intermedi
cryoglobulinem
vascul
smallsiz
vessel
leukocytoclast
vascul
caus
deposit
circul
immun
complex
consist
cryoglobulin
cryoglobulin
monoclon
polyclon
immunoglobulin
precipit
temperatur
redissolv
warm
occur
patient
variou
diseas
includ
macroglobulinemia
connect
tissu
diseas
chronic
infect
mani
case
idiopath
socal
essenti
mix
cryoglobulinemia
emc
cryoglobulinem
vascul
role
hepat
c
viru
hcv
pathogenesi
emc
rapidli
suspect
follow
identif
subsequ
confirm
sever
epidemiolog
laboratori
find
review
cacoub
et
al
key
role
hcv
pathogenesi
emc
demonstr
presenc
hcv
antigen
within
blood
vessel
skin
biopsi
agnello
abel
effici
ifna
addit
strike
argument
direct
link
hcv
emc
review
cacoub
et
al
hcv
lymphotrop
viru
chronic
infect
lymphocyt
may
give
rise
variou
autoimmun
lymphoprolif
disord
ferri
mascia
patient
cryoglobulinem
vascul
hcv
infect
trejo
et
al
ferri
et
al
nevertheless
less
hcvinfect
individu
develop
cryoglobulinem
vascul
ferri
mascia
find
may
indic
addit
factor
environment
genet
factor
de
et
al
involv
trigger
cryoglobulinem
vascul
hcvinfect
individu
strong
evid
suggest
persist
hcv
infect
induc
prolong
stimul
b
lymphocyt
lead
b
cell
clonal
expans
featur
emc
demonstr
either
peripher
blood
bone
marrow
liver
lamprecht
et
al
variou
mechan
may
support
b
cell
expans
hcvinfect
lymphocyt
accordingli
hcv
may
directli
activ
cell
bear
envelop
protein
abl
interact
molecul
cellsurfac
protein
part
costimulatori
receptor
b
lymphocyt
pileri
et
al
moreov
chromosom
transloc
commonli
describ
hcvrelat
cryoglobulinem
vascul
may
lead
enhanc
surviv
b
lymphocyt
ferri
mascia
collect
mechan
may
underli
product
antihcv
antibodi
form
persist
immun
complex
addit
hcvinfect
patient
molecular
mimicri
hcv
antigen
self
autoantigen
may
support
product
variou
organspecif
nonorganspecif
autoantibodi
therefor
underli
immunolog
disord
commonli
complic
hcv
infect
ferri
mascia
product
cryoprecipit
rheumatoid
factor
strike
featur
hcv
relatedcryoglobulinem
vascul
cutan
vascul
result
deposit
multifacet
cryoprecipit
immun
complex
consist
igm
rheumatoid
factor
link
igg
antihcv
reactiv
lamprecht
et
al
sansonno
dammacco
notic
hcvinfect
patient
prolong
b
cell
surviv
consequ
activ
protooncogen
may
lead
emerg
lymphoprolif
disord
malign
ferri
mascia
detect
hcv
infect
patient
emc
crucial
import
therapeut
implic
accordingli
patient
neg
hcv
serolog
marker
longstand
abnorm
liver
function
test
occult
hcv
infect
may
investig
analyz
presenc
hcv
rna
liver
biopsi
specimen
castillo
et
al
nonhcvrel
cryoglobulinem
vascul
studi
report
associ
variou
infecti
agent
hiv
bacillu
bcg
review
lamprecht
et
al
hbv
seem
play
minor
role
emc
repres
possibl
caus
agent
less
patient
trejo
et
al
ferri
et
al
data
howev
may
suggest
hbvcontain
immun
complex
play
pathogen
role
glomerulonephr
associ
cryoglobulinem
vascul
maya
et
al
urticari
vascul
uv
chronic
recurr
disord
character
cutan
present
resembl
urticaria
gastrointestin
musculoskelet
renal
pulmonari
system
may
also
involv
khasni
langford
skin
lesion
uv
commonli
persist
h
contrast
ordinari
urticaria
labil
biopsi
specimen
show
leukocytoclast
vascul
often
endotheli
damag
uv
usual
divid
normocomplementem
urticari
vascul
nuv
hypocomplementem
urticari
vascul
huv
relat
entiti
clearli
defin
davi
brewer
patient
huv
like
system
involv
angioedema
glomerulonephr
nuv
davi
brewer
huv
case
idiopath
also
occur
patient
infect
neoplasia
hematolog
diseas
connect
tissu
diseas
system
lupu
erythematosu
sle
syndrom
davi
brewer
activ
phase
diseas
patient
elev
erythrocyt
sediment
rate
hypocomplementemia
depress
antibodi
detect
patient
huv
syndrom
huv
also
call
mcduffi
syndromeallow
classif
entiti
autoimmun
diseas
wisnieski
antibodi
may
also
seen
autoimmun
condit
sle
whether
antibodi
implic
pathogenesi
huv
sle
remain
unclear
howev
sever
data
suggest
antibodi
pathogen
kallenberg
may
contribut
glomerulonephr
sle
react
bound
dna
antidna
complex
latter
complex
becom
less
solubl
deposit
within
vascular
wall
thu
trigger
inflamm
destruct
wisnieski
davi
brewer
huv
share
mani
featur
sle
author
suggest
huv
subtyp
sle
davi
brewer
genet
environment
factor
may
possibl
contribut
pathogenesi
huv
yet
etiolog
remain
unknown
davi
brewer
goodpastur
gp
syndrom
rare
autoimmun
diseas
character
rapidli
progress
crescent
glomerulonephr
pulmonari
hemorrhag
berg
presenc
antibodi
direct
glomerular
basement
membran
gbm
serum
characterist
featur
gp
syndrom
immunofluoresc
analysi
biopsi
show
linear
deposit
antibodi
along
glomerular
alveolar
basement
membran
autoantibodi
mainli
direct
domain
chain
type
iv
collagen
sau
et
al
although
variou
organ
contain
type
iv
collagen
autoantibodi
particularli
target
basement
membran
kidney
alveoli
increas
express
access
target
epitop
berg
pathogen
role
antibas
membran
antibodi
fulli
demonstr
antibodi
transfer
experi
rodent
ooi
et
al
antigbm
antibodi
trigger
cellular
cytotox
mechan
complement
cascad
activ
lead
interrupt
membran
integr
along
rapid
inflammatori
respons
tissu
damag
target
epitop
normal
expos
socal
cryptic
antigen
wiesland
et
al
suggest
initi
inflammatori
condit
infect
renal
ischemia
may
alter
structur
gbm
lead
exposur
cryptic
epitop
loss
immun
toler
kalluri
ooi
et
al
interestingli
evid
genet
suscept
gp
syndrom
illustr
studi
demonstr
associ
diseas
therefor
suggest
role
cell
pathogenesi
diseas
phelp
ree
henc
sever
experiment
model
antigbm
glomerulonephr
support
hypothesi
ooi
et
al
howev
studi
unabl
differenti
role
cell
gener
autoantibodi
product
trigger
tissu
damag
ooi
et
al
interestingli
report
kalluri
et
al
demonstr
passiv
transfer
iv
antibodi
celldefici
mice
fail
produc
nephriti
suggest
implic
cell
effector
player
glomerular
injuri
accordingli
cell
epitop
within
domain
describ
either
human
rodent
strong
evid
point
involv
tcellmedi
immun
goodpastur
glomerulonephr
review
ooi
et
al
wegen
granulomatosi
wg
microscop
polyangi
mpa
churgstrauss
syndrom
css
idiopath
necrot
crescent
glomerulonephr
ncgn
group
diseas
strongli
associ
anca
commonli
refer
ancaassoci
vascul
character
system
necrot
vascul
case
immun
deposit
found
lesion
therebi
differenti
vascul
mediat
deposit
immun
complex
ancaassoci
vasculitid
socal
pauciimmun
diagnosi
smallvessel
vasculitid
base
presenc
characterist
clinic
histolog
find
wg
granulomat
necrot
smalland
mediumvessel
vascul
predominantli
involv
upper
lower
airway
well
kidney
frequent
vari
multisystem
manifest
khasni
langford
wg
affect
either
male
femal
occur
adult
age
upper
lower
respiratori
tract
lesion
character
granulomat
inflamm
contain
abund
macrophag
lymphocyt
latter
frequent
cluster
lymphoid
tissuelik
structur
voswinkel
et
al
renal
lesion
wg
focal
segment
necrot
crescent
glomerulonephr
immun
complex
deposit
khasni
langford
patient
posit
result
mpa
necrot
smallvessel
vascul
share
mani
featur
wg
lack
granulomat
inflamm
mpa
occur
frequent
male
averag
age
onset
year
khasni
langford
involv
commonli
kidney
lesser
extent
lung
multisystem
manifest
involv
joint
skin
gastrointestin
tract
frequent
found
lung
inflamm
involv
capillari
absenc
linear
immunofluoresc
differenti
diseas
goodpastur
syndrom
renal
histolog
mpa
similar
seen
wg
anca
posit
approxim
case
either
mpo
may
recogn
css
character
associ
system
vascul
asthma
hypereosinophilia
histolog
featur
css
includ
eosinophil
tissu
infiltr
extravascular
granuloma
format
smallvessel
necrot
vascul
khasni
langford
anca
less
frequent
posit
approxim
case
recogn
predominantli
mpo
author
suggest
css
patient
antineutrophil
antibodi
may
phenotyp
differ
anca
neg
pagnoux
et
al
necrot
glomerulonephr
predomin
ancaposit
patient
wherea
cardiomyopathi
often
observ
ancaneg
patient
seen
substanti
evid
anca
directli
involv
endotheli
damag
character
ancaassoci
vascul
anca
play
promin
role
mainli
activ
neutrophil
howev
cell
target
anca
monocyt
glomerular
epitheli
cell
also
propos
implic
vascular
damag
remain
confirm
savag
et
al
implic
lymphocyt
effector
player
also
less
evid
studi
demonstr
presenc
cell
vascular
tissu
site
particularli
interstiti
periglomerular
region
kidney
lesion
cunningham
et
al
aasarod
et
al
weidner
et
al
howev
accumul
report
demonstr
activ
cellmedi
immun
focus
abnorm
peripher
lymphocyt
berden
et
al
nevertheless
variou
experiment
studi
provid
evid
role
lymphocyt
respons
mediat
glomerular
damag
crescent
format
ancaassoci
vascul
holdsworth
et
al
recent
experiment
model
provid
vivo
evid
interact
humor
cellular
immun
trigger
renal
injuri
ruth
et
al
implic
cellular
immun
also
suggest
develop
granulomat
lesion
wg
csernok
et
al
voswinkel
et
al
recent
suggest
granulomat
format
lymphoid
tissuelik
structur
give
rise
autoantibodi
product
activ
selfreact
lymphocyt
essenti
drive
b
cell
matur
format
final
role
eosinophil
css
suspect
fulli
elucid
wide
establish
pathophysiolog
css
involv
three
potenti
mechan
underli
three
main
success
phase
diseas
asthma
tissu
eosinophil
infiltr
necrot
vascul
although
anca
contribut
develop
vascul
lesion
eosinophil
tissu
infiltr
togeth
relat
cytotox
releas
cytotox
enzym
may
respons
tissu
lesion
cardiomyopathi
pulmonari
infiltr
kallenberg
pagnoux
et
al
although
effector
mechan
trigger
tissu
damag
ancaassoci
vascul
mainli
identifi
initi
event
trigger
breakdown
selftoler
anca
antigen
still
debat
anca
probabl
produc
secondari
exposur
cryptic
epitop
pathogen
mechan
may
underli
loss
immun
toler
promin
role
lymphocyt
loss
immun
toler
like
sever
report
document
capac
peripher
cell
either
activ
inact
patient
prolifer
mpo
suggest
loss
lymphocyt
toler
neutrophil
antigen
review
savag
et
al
fact
anca
igg
isotyp
support
implic
lymphocyt
drive
secondari
immun
respons
neutrophil
antigen
moreov
treatment
target
cell
induc
remiss
wg
lockwood
et
al
schmitt
et
al
addit
function
defect
circul
regulatori
lymphocyt
reg
recent
demonstr
patient
wg
suggest
implic
reg
abnorm
loss
immun
homeostasi
abdulahad
et
al
howev
function
defect
demonstr
patient
remiss
effect
immunosuppress
therapi
could
exclud
berden
et
al
yet
implic
environment
genet
factor
loss
immun
homeostasi
outcom
diseas
frequent
suggest
experiment
data
show
presenc
anca
may
suffici
induc
diseas
manifest
support
hypothesi
risk
factor
includ
genet
factor
polymorph
antitrypsin
fc
gamma
receptor
gene
drug
propylthiouracil
hydralazin
chemic
substancesin
particular
silica
microbi
agent
kallenberg
et
al
tervaert
heeringa
among
genet
factor
polymorph
may
lead
enhanc
express
antigen
neutrophil
surfac
suggest
alter
regul
express
may
play
role
pathogenesi
gencik
et
al
nevertheless
infecti
factor
seem
like
factor
suscept
implic
staphylococcu
aureu
propos
popa
et
al
wg
chronic
carriag
aureu
constitut
risk
factor
develop
exacerb
popa
et
al
sever
hypothet
mechan
infecti
factor
may
underli
autoimmun
tervaert
heeringa
trigger
exacerb
kallenberg
et
al
propos
interest
work
bron
et
al
suggest
staphylococc
acid
phosphatasea
cation
protein
aureusmay
bind
endotheli
cell
local
glomeruli
antibodi
specif
phosphatas
present
patient
wg
may
interact
plant
antigen
therebi
initi
vascul
anoth
attract
theori
call
autoantigen
complementar
propos
initi
autoimmun
respons
protein
complementari
structur
autoantigen
patient
also
antibodi
react
peptid
complementari
show
strong
homolog
protein
mani
microb
virus
particularli
aureu
preston
et
al
altern
role
superantigen
peptidoglycan
aureusinduc
skew
cell
respons
pathogen
thelper
cell
exclud
abdulahad
et
al
final
role
antibodi
well
establish
pathogenesi
ancaassoci
vascul
broad
rang
therapi
target
humor
immun
plasmapheresi
ivig
test
patient
efficaci
still
confirm
random
trial
addit
preliminari
studi
suggest
efficaci
antibodi
rituximab
keogh
et
al
keogh
et
al
patient
refractori
wg
involv
aureu
wg
may
therapeut
consequ
treatment
cotrimoxazol
led
reduct
incid
relaps
stegeman
et
al
recent
find
support
contribut
cellular
immun
ancaassoci
diseas
may
provid
new
therapeut
strategi
refractori
patient
despit
recent
advanc
immunolog
genet
etiolog
primari
vascul
remain
larg
undetermin
yet
consider
progress
understand
pathophysiolog
mechan
system
vascul
thu
provid
signific
insight
ongo
work
understand
pathogenesi
vascul
may
contribut
develop
novel
therapeut
approach
